Neurology

Briumvi, Ocrevus, Tysabri, Tyruko

multiple-sclerosis

Conditions

Condition

Multiple Sclerosis Infusions in Toms River, NJ

Learn about multiple sclerosis symptoms and provider-prescribed disease-modifying infusions at Infuse Care.

Specialty

Therapies we administer

Overview

Multiple sclerosis (MS) is a condition in which the immune system damages myelin in the brain, spinal cord and optic nerves, which slows or disrupts nerve signals. Most people first have a relapsing form, with attacks followed by partial or full recovery. Some have a progressive form from the start. Starting disease-modifying therapy early may help reduce relapses and new areas of damage.

Common Signs and Symptoms

  • Blurred vision or eye pain (optic neuritis)
  • Numbness or tingling
  • Weakness, stiffness or muscle spasms
  • Problems with balance or dizziness
  • Fatigue
  • Bladder or bowel changes
  • Changes in memory or concentration

When to Contact a Provider

New vision loss, weakness or numbness that lasts more than a day should be checked promptly. If you already have MS, tell your neurologist about new or worsening symptoms.

How Treatment May Help

Disease-modifying therapies (DMTs) do not cure MS, but they may help reduce relapses, limit new lesions on MRI and slow disability. Relapses may be treated with steroids, and rehabilitation can help with function.

Therapies That May Be Available at Infuse Care

  • Ocrevus (ocrelizumab): IV infusion; two starting doses two weeks apart, then every six months; for relapsing MS and primary progressive MS
  • Briumvi (ublituximab): IV infusion; two starting doses, then every 24 weeks; for relapsing MS
  • Tysabri (natalizumab): IV infusion every four weeks; for relapsing MS
  • Tyruko (natalizumab, a biosimilar to Tysabri): IV infusion every four weeks; for relapsing MS

Safety and Monitoring

Ocrevus and Briumvi can cause infusion reactions, so medicines are given beforehand and you are monitored. Your provider will test for hepatitis B before starting and watch for infections.

Tysabri and Tyruko carry a risk of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection. JC virus antibody testing and enrollment in a safety program are required. Report new or unusual neurological symptoms right away.

Your prescribing provider decides which treatment is right for you. Infuse Care administers prescribed therapies after a referral, a clinical review and any required insurance authorization, and we keep your provider's office updated on your care.

More in this specialty

For patients

Ready to start treatment?

Call our team and we'll coordinate with your doctor and insurance.

Get started

For referring providers

Find the order form

Search 74 fillable order forms by medication, then fax with clinicals to (732) 960-3449.

Order forms